期刊文献+

反应停对急性肝衰竭的的预防作用 被引量:5

The preventive effect of thalidomide on acute liver failure
下载PDF
导出
摘要 目的 探讨反应停 (Thal)对急性肝衰竭的预防作用。方法 用D 半乳糖胺 (D GalN ,60 0mg/kg ,ip)和细菌脂多糖 (LPS ,5 μg/只 ,H)复制大鼠急性肝衰竭模型 ,观察Thal对急性肝衰竭死亡率、细胞因子、转氨酶、肝组织形态学和单个核细胞TNFαmRNA表达的影响。结果 Thal可降低急性肝衰竭的死亡率、TNFα和转氨酶的水平 (P <0 .0 5 ) ,减轻肝细胞坏死的程度 ,抑制单个核细胞TNFαmRNA的表达。 Aim To understand the preventive effect of thalidomide on acute live failure.Methods D-Galactosamine (D-GalN,600mg/kg,ip) and lipopolysaccharide(LPS,5μg/rat,H) were used to reproduce the model of acute liver failure on Wistar rats.The mortality of the models was counted.The plasma peak levels of various cytokines and transaminases were measured.The pathological alterations of the livers were examined with hematoxylin and eosin stain under light microscopy.The expression of TNF α mRNA was determined by Dot Blot hybridization combined with semiquantitative analyse.Results It was found that Thal could lower the mortality of the models (P<0.05),reduce the peak levels of plasma cytokines,especially TNF α and transaminases (P<0.05),alleviate the degree of liver injury and supress the expression of TNF α mRNA (P<0.05).Conclusion These results fully demonstrated that Thal had positively preventive effects on acute liver failure as it did in the other diseases.Even though it was found that Thal possessd teratogenic effect during pregnancy,it was still belived that Thal had an important curative significance in the treatment of patients who were not pregnancy.
机构地区 解放军第
出处 《胃肠病学和肝病学杂志》 CAS 2000年第1期39-41,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 反应停 急性肝衰竭 肿瘤坏死因子 预防 Thalidomide Acute liver failure Tumor necrosis factor Bleed
  • 相关文献

参考文献9

  • 1Muto Y,Nouri-Aria KT, Meager A,et al. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet, 1988,2:72- 76.
  • 2Chouaib S, Branellec D and Buman WA. More insights into the complex physiology of TNF. Immunol Today, 1991,21:141 - 8.
  • 3Sampaio EP, Kaplen G, MIranda A, et al. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum Leprosum. J Infect Dis,1993,168:408- 4.
  • 4Ashby J.Thalidomide is not a mutagen. Nature,1997,389:118.
  • 5Zwingenberger K and Wnenddt S. Immunomdululation by thalidomide: synthetic review of the literature and of unpublished observations: J Inflam,1996,46:177~211.
  • 6Sampaio E,Sarmo E,Gallily R, et al.Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulating human monocytes. J Exp Med, 1991,173:699 ~ 703.
  • 7Mchugh S,Rifkin 1,Deighton J,et al. The immunosuppressive drug thalidomide induces T helper cell type Ⅱ and concomitantly inhibits Thlcytokine production in mitogen and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol, 1995,99:160 ~ 168.
  • 8Tavares JL, Wsngoo A,Dilworth P,et al.Thalidomide reduces tumor necrosis factor a production by human alveolar macrophages. Res Med,1997,91:31~39.
  • 9Moreira AL,Sampaio EP,Zmuidzinas A, et al. Thalidomide exerts its inhibition action on tumor necrosis factor alpha by enhancing mRNA degredation. J Exp Med, 1993,177:1675 ~ 1680.

同被引文献75

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部